Stem cells and the natural history of lung cancer: Implications for lung cancer screening

Clinical Cancer Research

Volumn 15, Issue 7, 2009, Pages 2215-2218

  Van Klaveren, Rob J ^a   Van'T Westeinde, Susan C ^a   De Hoop, Bart Jan ^b   Hoogsteden, Henk C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER GROWTH; CANCER MODEL; CANCER SCREENING; CANCER STAGING; CANCER STEM CELL; GROWTH CURVE; HUMAN; IMMUNE SYSTEM; LUNG CANCER; LUNG CARCINOGENESIS; METASTASIS; MICROENVIRONMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASTIC STEM CELLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65249162825     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1920     Document Type: Review

References (32)

1. Van lersel CA, de Koning HJ, Draisma G, et al. Risk- based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74. PubMed doi:10.1002/ijc.22134.
2. Henschke CI, Yankelevitz DF, Libby DM, et al.; The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. PubMed doi:10.1056/NEJMoa060476.
3. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-7. PubMed doi:10.1016/S0140-6736(03)14188-8.
4. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-65. PubMed doi:10.1148/ radiol.2351041662.
5. West GB, Brown JH, Enquist BJ. A general model for oncogenetic growth. Nature 2001;413:628-31. PubMed doi:10.1038/35098076.
6. Guiot C, Degiorgis PG, Delsanto PP, Gabriele P, Deisboeck TS. Does tumor growth follow a "universal law"? J Theor Biol 2003;225:147-51. PubMed doi:10.1016/S0022-5193(03)00221 -2.
7. Guiot C, Delsanto PP, Carpinteri A, Pugno N, Mansury Y, Deisboeck TS. The dynamic evolution of the power exponent in a universal growth model of tumors. J Theor Biol 2006;240:459-63. PubMed doi:10.1016/j.jtbi.2005.10.006.
8. Delsanto PP, Condat CA, Pugno N, Gliozzi AS, Griffa M. A multilevel approach to cancer growth modeling. J Theor Biol 2008;250:16-24. PubMed doi:10.1016/j.jtbi.2007.09.023.
9. Schabel FM, Jr. Concepts for systemic treatment of micrometastases. Cancer 1975;35:15-24. PubMed doi :10.1002/1097-0142(197501)35:1<15::AID- CNCR2820350104>3.0.CO;2-W.
10. Tubiana M. The growth and progression of human tumors: implications for management strategy. Radiother Oncol 1986;6:167-84. PubMed doi:10.1016/S0167- 8140(86)80151-7.
11. Henschke C,Yankelevitz DF, Miettinen OS,TheInternational Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 2006;166:321 -5. PubMed doi:10.1001/archinte.166.3.321.
12. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forth coming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-14. PubMed doi:10.1097/JTO.0b013e31812f3c1a.
13. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008;7:781-92.
14. Patz EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;30:1627-33. doi:10.1056/NEJM200011303432208.
15. Jennings SG, Winer-Muran HT, Tann M, Ying J, Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 2006;241:554-63. PubMed doi:10.1148/radiol.2412051185.
16. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol 2008;9:693-7. PubMed doi:10.1016/S1470-2045(08)70176-1.
17. Bach PB, Jett JR,Pastorino U,TockmanMS,Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-61. PubMed doi:10.1001/jama.297.9.953.
18. Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells. Strange bed fellows? Am J Respir Crit Care Med 2007;175:547-53. PubMed doi:10.1164/rccm.200607-984PP.
19. Kakarala M, Wicha MS. Cancer stem cells: implications for cancer treatment and prevention. Cancer J 2007;13:271-5.PubMed doi:10.1097/PPO. 0b013e318156da4e.
20. Wu M, Wei Y. Development of respiratory stem cells and progenitor cells. Stem Cells Dev 2004;13:607-13. PubMed doi:10.1089/scd.2004.13.607.
21. Loebinger MR, Aguilar S, Janes SM. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond) 2008;114:99-108. PubMed doi:10.1042/CS20070073.
22. Mimeault M, Hauke R, Metha PP, Batra SK. Recent advancesincancerstem/ progenitorcell research: therapeutic implications to overcome resistance to the most aggressive cancers. J Cell Mol Med 2007;11:981 - 1011.doi:10.1111/j.1582- 4934.2007.00088.x.
23. Eramo A, Lotti F, Sette G, et al Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504-14. PubMed doi:10.1038/sjcdd.4402283
24. Kotton DN, Fine A. Lung stem cells. Cell Tissue Res 2008;331:145-56. PubMed doi:10.1007/s00441- 007-0479-2.
25. Peacock CD, Watkins N. Cancer stem cells and the ontogeny of lung cancer. J Clin Oncol 2008;26: 2883-9. PubMed doi:10.1200/JCO.2007.15.2702.
26. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895-902. PubMed doi:10.1038/nrc1232.
27. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar cells in normal lung and lung cancer. Cell 2005;121:823-35. PubMed doi:10.1016/j.cell.2005.03.032.
28. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217-26. PubMed doi:10.1056/NEJMoa063994.
29. Bissell MJ, Radisky D. Putting tumors in context. Nat Rev Cancer 2001;1:46-51. PubMed doi:10.1038/35094059.
30. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63. PubMed doi:10.1038/nature06188.
31. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cell control the angiogenetic switch in mouse lung metastasis. Science 2008;319:195-8. PubMed doi:10.1126/science.1150224.
32. Rafi S, Lyden D. A few to flip the angiogenetic switch. Science 2008;319:163-4. PubMed doi:10.1126/science.1153615.